Manuscripts can be pre-screened by the Editor-in-Chief and Deputy Editors. Please email all manuscript files to the Publishing Editor prior to submitting via the submission site. Pre-screened papers will then be offered peer review after formal submission.
Featured Collections
- Biomarkers for Early Detection of Cardiotoxicity
- Cardio-Oncology and Immunotherapy
- Radiation-Induced Cardiovascular Disease
Biomarkers for Early Detection of Cardiotoxicity
This Collection seeks to highlight cutting-edge research on the identification and validation of biomarkers that can predict cardiotoxicity at an early stage.
Submission Deadline: 30 September 2025
Cardio-Oncology and Immunotherapy
This Collection aims to explore the intersection of cardiovascular health and cancer immunotherapy, a rapidly growing field as novel treatments like immune checkpoint inhibitors and CAR T-cell therapies become more prevalent.
Submission Deadline: 30 September 2025
Radiation-Induced Cardiovascular Disease
This Collection aims to bring together the latest research on the cardiovascular effects of radiation exposure, both from medical treatments such as radiotherapy and from environmental or occupational sources.
Submission Deadline: 30 September 2025
Podcast: All Things Cardio-Oncology
Listen to the podcast of the International Cardio-Oncology Society here.
Certification Exam in Cardio-Oncology Knowledge
Apply for the IC-OS Certification Exam in Cardio-Oncology Knowledge here.
IC-OS Board Exam Review Book
Purchase the IC-OS Board Exam Review Book here.
Practical approaches to care
We're excited to announce a new Cardio-Oncology initiative: "Practical Approaches to Cardio-Oncology Care." We invite manuscripts dealing with state-of-the-art management of common clinical cardio-oncology issues and toxicities, e.g., “How to manage pericardial effusions.” As part of a new series, we will offer expedited reviews for rapid processing. See here for details.
Articles
-
-
Alternative mRNA splicing in anthracycline-induced cardiomyopathy – a COG-ALTE03N1 report
-
Impact of hospital variation in hematologic malignancy patient proportions on outcomes of chronic lymphocytic leukemia patients undergoing cardiac surgery: insights from nationwide data analysis
-
Development and validation of an early prediction model for cardiac death risk in patients with light chain amyloidosis: a multicenter study
-
Methylation-based biological age and cardiotoxicity risk in breast cancer patients treated with trastuzumab
-
Management of atrial fibrillation in patients taking targeted cancer therapies
-
5-FU induced cardiotoxicity: case series and review of the literature
-
Etiology and management of hypertension in patients with cancer
-
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
-
Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic
Manuscript pre-screening
Apply to our Trusted Reviewer Board
Cardio-Oncology has launched a new Trusted Reviewer Board composed of early career researchers. To learn more, and to apply, please visit the application form.
By joining the board as a Trusted Reviewer, you will be part of our very first official Reviewer Board, gain editorial experience, and refine your reviewing skills. The role comes with a plethora of other benefits, including:
- Free of charge access to some Springer Nature Masterclasses.
- Access to the Springer Nature Research Communities.
- Recognition for your contribution in the form of sharable certificates and featuring your name on the journal Editorial Board page.
Aims and scope
The mission of Cardio-Oncology is to promote the science, technology, practice, and betterment of the public health of the emerging field of cardio-oncology. We are an international, open access journal that strives to publish original, important, valid, peer-reviewed articles on a diverse range of medical topics related to the cardiovascular effects of cancer treatments. Read more here.
Cross-journal collections
We are proud to announce that Cardio-Oncology is taking part in two new cross-journal collections "Cancer Disparities" and "Long-term Impact of COVID in Cancer Patients." Both collections are now open for submissions.
About the society
Cardio-Oncology is the official journal of the International Cardio-Oncology Society (ICOS). The society brings together cardio-oncologists from around the world with the aim of reducing cardiovascular disease in cancer patients and thereby saving patients' lives. For more information about this important work, please visit the ICOS website.
Peer Review Taxonomy
This journal is participating in a pilot of NISO/STM's Working Group on Peer Review Taxonomy, to identify and standardize definitions and terminology in peer review practices in order to make the peer review process for articles and journals more transparent. Further information on the pilot is available here.
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: None
We welcome your feedback on this Peer Review Taxonomy Pilot. Please can you take the time to complete this short survey.
-
Affiliated with
-
Cardio-Oncology is affiliated with the International Cardio-Oncology Society (ICOS).
-
- Editorial Board
- Manuscript editing services
- Instructions for Editors
- Contact Support for Editors
- Sign up for article alerts and news from this journal
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 3.2
5-year Journal Impact Factor: N/A
Source Normalized Impact per Paper (SNIP): 0.822
SCImago Journal Rank (SJR): 0.958Speed 2024
Submission to first editorial decision (median days): 13
Submission to acceptance (median days): 100Usage 2024
Downloads: 253,129
Altmetric mentions: 271
Institutional membership
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).